Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $263,635 | $105,979 | $74,650 |
| - Cash | $190,055 | $125,331 | $131,716 | $98,776 |
| + Debt | $266 | $492 | $563 | $5,299 |
| Enterprise Value | – | $138,796 | -$25,174 | -$18,827 |
| Revenue | $3,290 | $1,998 | $2,429 | $2,582 |
| % Growth | 64.7% | -17.7% | -5.9% | – |
| Gross Profit | $1,923 | -$1,274 | $1,486 | $1,399 |
| % Margin | 58.4% | -63.8% | 61.2% | 54.2% |
| EBITDA | -$31,549 | -$27,813 | -$16,336 | -$21,612 |
| % Margin | -958.9% | -1,392% | -672.5% | -837% |
| Net Income | -$32,010 | -$28,272 | -$16,829 | -$22,108 |
| % Margin | -972.9% | -1,415% | -692.8% | -856.2% |
| EPS Diluted | -3.59 | -3.86 | -2.84 | -9.77 |
| % Growth | 7% | -35.9% | 70.9% | – |
| Operating Cash Flow | -$28,782 | -$14,833 | -$16,579 | -$14,630 |
| Capital Expenditures | -$962 | -$2,539 | -$6 | -$3 |
| Free Cash Flow | -$29,744 | -$17,372 | -$16,585 | -$14,633 |